About the Centre

About Addiction

About Mental Health

Community Health & Education

Research

 
CAMH

Research Annual Report
2001

Clinical Research Department

 
CAMH Foundation
Education
CAMH Publications
Volunteers
Career Opportunities
 

Addictions

Head: Dr. Tony Toneatto


Cognitive Therapy for Problem Gambling

Very little is known about treatments for problem gambling. This study compares four cognitive-behavioural treatments commonly used to treat substance addiction: cognitive therapy, behaviour therapy, motivational therapy and minimal intervention. This randomized control trial will help produce some clear answers on how to best help the gambling population.


Comorbidity of Pathological Gambling, Psychiatric Disorders and Substance Use Disorders

Very little is known about the prevalence of pathological gambling among clients seeking treatment for other addiction and/or mental health concerns. This archival study will examine an existing large Ontario outpatient clinical data set, in combination with chart reviews, to gain a better understanding of how concurrent pathological gambling affects the clinical course of treatment and treatment outcomes of addictive disorders.


Naltrexone Treatment of Concurrent Alcohol Dependence and Pathological Gambling

There is growing interest in discovering effective medications for treating problem gambling. Naltrexone has been found to be an effective medication for treating alcohol addiction. Our belief that alcohol and gambling activate similar rewarding-related brain sites gives us cause to believe that naltrexone may also be helpful in treating gambling disorders. This study will compare the effectiveness of naltrexone to a placebo in treating concurrent gambling and alcohol addiction.


Concurrent Psychiatric Disorders and Problem Gambling

This study will describe the history of other psychiatric disorders and addiction problems in individuals who are gambling heavily, those who have recovered from a gambling problem and non-problem or recreational gamblers. Such information may help identify different sub-types of problem gambling behaviour and influence treatment development.


Gambling Problems in Males And Females in Ontario

The majority of our knowledge about problem gambling is based on the study of men. To better understand this clinical condition, it is necessary to learn more about women who have gambling problems. This study uses a large number of gambling-related questionnaires to compare males and females who have gambling problems. The questionnaires assess gambling behaviour, gambling expectancies, gambling beliefs, self-esteem, stress, social support, dissociation, problem-solving, psychiatric symptoms and coping styles. Such information may help to develop more effective treatments for gambling problems in both men and women.


Client-Centered Methadone Treatment Program

The methadone program designed by one of CAMH's founding partners, the Addiction Research Foundation, was redesigned to serve clients more efficiently using a client-centred model and harm reduction principles. The new program evaluates both clinical efficacy and cost-effectiveness using a newly developed harm scale. This project has been fully integrated into the clinical program and has been operating for four years.


Comparison of the Effects of Heroin and Hydromorphone

This ongoing study will be the first to assess and compare the pharmacological profiles of heroin and hydromorphone, to determine whether the acute subjective and physiological effects of heroin and hydromorphone differ and to discover whether the route of administration (intravenous versus subcutaneous) alters the time course of their effects.


Smoking Cessation

This is a randomized double blind placebo-controlled 12-week smoking cessation trial of Zyban (150 mg bid). It is a Phase IV multi-centre clinical efficacy and safety trial of Zyban in adult smokers previously treated with Zyban, who failed in treatment or relapsed after treatment.


CBT for Concurrent Panic Disorder and Alcohol Problems

The goal of this study is to improve treatment for concurrent panic disorder and alcohol problems. This will be done by comparing a treatment specifically designed for this type of concurrent disorder to two other treatments that target either the anxiety disorder alone or the alcohol problem alone. The results will tell us whether it is necessary to specifically treat both components of this concurrent disorder.


Prescription Opioid Dependence

Oral prescription opioid dependence, its causes, comorbidity and outcomes are poorly understood. This study will help us understand the characteristics of people dependent on oral prescription opioids and compare them to people on other opioids (such as heroin). It may also help us to understand the role of dysphoric mood and pain (and its neurobiological correlates) in how problems develop and possibly find treatment alternatives for these problems.


Adolescent Heroin Use

Available evidence suggests that heroin use by adolescents is on the rise. There is a significant lack of appropriate treatment services for these young people. The objectives of this study are to determine the patterns of heroin use in a group of young people, identify the barriers to accessing treatment, identify other relevant issues in their lives that may affect the success
of a treatment program and allow participants to see their own contribution to developing the treatment program.

to top

 
You are Here :
CAMH > Research > Research Annual Report 2001 > Addictions
 
On this page
Cognitive Therapy for Problem Gambling
Comorbidity of Pathological Gambling, Psychiatric Disorders and Substance Use Disorders
Naltrexone Treatment of Concurrent Alcohol Dependence and Pathological Gambling
Concurrent Psychiatric Disorders and Problem Gambling
Gambling Problems in Males And Females in Ontario
Client-Centered Methadone Treatment Program
Comparison of the Effects of Heroin and Hydromorphone
Smoking Cessation
CBT for Concurrent Panic Disorder and Alcohol Problems
Prescription Opioid Dependence
Adolescent Heroin Use
Related Pages
Index of Clinical Research Department Pages 2001
PDF of Clinical Research Department 2001
Research Annual Report 2001 complete PDF
Research Annual Report 2001 Index
Research Annual Report 2000 Index
Guide to the Centre > Clinical Research Department
 
How to Reach Us
Looking for more information on addiction?
SANO
SANO
The Substance Abuse Network of Ontario

 

 


For general information on addiction and mental health:

Call the R. Samuel McLaughlin Addiction and Mental Health Information Centre

Toll free in Ontario Tel:1-800-463-6273
or local (416) 595-6111

www.camh.net/mclaughlin

DISCLAIMER: The Centre is not able to provide diagnostic, treatment or referral services through the Internet. Individuals should contact their family doctors, or their local mental health or addiction agency for further information.


to top

© Copyright
Centre for Addiction and Mental Health

33 Russell Street, Toronto
Ontario, Canada M5S 2S1.
Telephone: (416) 535-8501

The Centre is fully affiliated with
the
University of Toronto.

A Pan American Health Organization
and World Health Organization
Collaborating Centre

For inquiries regarding the content of this page, contact

Please direct technical questions or comments about this site to

If you are a spammer or spam-harvesting robot, please send mail to imaspammer-on@lists.camh.net.

     


 


This page was last modified on Sunday, February 9, 2003 5:58 PM